Joshua Isner Sells 20,000 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXON) President Joshua Isner sold 20,000 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Joshua Isner also recently made the following trade(s):

• On Tuesday, September 10th, Joshua Isner sold 25,811 shares of Axon Enterprise stock. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24.

Axon Enterprise Trading Up 1.0 %

Shares of NASDAQ:AXON traded up $6.11 during mid-day trading on Wednesday, hitting $601.29. The company had a trading volume of 850,627 shares, compared to its average volume of 549,467. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a one year low of $220.51 and a one year high of $624.84. The firm has a fifty day moving average price of $423.98 and a 200 day moving average price of $351.79. The company has a market capitalization of $45.85 billion, a PE ratio of 155.37, a price-to-earnings-growth ratio of 14.95 and a beta of 0.94.

Hedge Funds Weigh In On Axon Enterprise

A number of institutional investors and hedge funds have recently made changes to their positions in AXON. Blue Trust Inc. increased its holdings in shares of Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after acquiring an additional 79 shares in the last quarter. Quent Capital LLC raised its holdings in Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares during the last quarter. Brooklyn Investment Group bought a new position in shares of Axon Enterprise in the third quarter valued at $41,000. Asset Dedication LLC acquired a new position in shares of Axon Enterprise during the second quarter valued at about $47,000. Finally, Planning Capital Management Corp increased its position in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent analyst reports. The Goldman Sachs Group raised their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. JMP Securities raised their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Barclays increased their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Finally, Craig Hallum raised their target price on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.